Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Waste and Recycling
- Monitoring and Testing
- Environmental
- Health and Safety
- Air and Climate
- Construction & Construction Materials
- Banking & Finance / Insurance / Legal
- Aerospace & Air Transport
- Forestry & Wood
- Glassware
- Retail
- Packaging
- Metal
- Plastics & Resins
- Pulp & Paper
- Soil and Groundwater
- University / Academia / Research
- Government
- Publishing / Media / Marketing
- Food and Beverage
- Energy
Drug Approval Suppliers & Manufacturers
38 companies found
based inThousand Oaks, CALIFORNIA (USA)
Amgen is one of the world™s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen is committed to ...
based inLondon, UNITED KINGDOM
Informa is a leading business intelligence, academic publishing, knowledge and events business, operating within the Knowledge and Information Economy. We serve commercial, professional and academic communities in many different sectors by helping ...
based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
based inVerduno, ITALY
Fisioline is an italian manufacturer of electromedical and electroasthetic equipment which was established in 1985 and has been operating internationally for several years. Within Fisioline, the Research and Development department holds a prominent ...
based inTel Aviv, ISRAEL
The volume of human molecular data is growing exponentially, but our analytic capabilities are growing linearly, at best. Humans alone cannot process all this data. What’s needed is a technology capable of digesting, organizing and making sense of ...
based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
based inEschborn, GERMANY
When we looked at the decision making landscape in organizations and observed that the available technologies and models were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and ...
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...
based inSan Jose, CALIFORNIA (USA)
Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates, ensuring continuous ...
based inGuro-gu, SOUTH KOREA
NanoEntek possesses a key piece of Bio-MEMS technology that seamlessly integrates biotechnology with Micro-electro Mechanical Systems(MEMS), which is heralded as the most advanced technology in the 21st century. To realize this technology, ...
based inRockville, MARYLAND (USA)
ExeGi Pharma develops live biotherapeutic and probiotic medicines for a wide variety of therapeutic needs. Our team consists of experts in the field with extensive product and clinical development, manufacturing, and commercialization of live ...
based inNew York, NEW YORK (USA)
SIGA Technologies, Inc. is a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear ...
In October 2018, SIGA entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) with a focus on Good Laboratory Practice (GLP) studies of TPOXX® ...
based inParamus, NEW JERSEY (USA)
Starton is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer. Focused on continuous ...
STAR-LLD is in development in two continuous delivery systems: subcutaneous and transdermal. STAR-LLD is being developed to establish the only IMiD (immunomodulatory drug) approved for CLL. CLL is the most common ...
based inSeattle, WASHINGTON (USA)
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. We are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental ...
based inBangalore, INDIA
Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response ...
Accelerate drug development timelines, reduce risks and lower costs. Our biosimulation platform predicts human clinical response to investigational drug candidates YEARS earlier than traditional development ...
based in, CALIFORNIA (USA)
Founded by lateral-flow scientists in 2009, Advin Biotech, Inc. is an FDA registered purveyor of lateral-flow rapid diagnostics, specializing in the innovative design, structured development, and efficient manufacture of premium quality, ...
based inBudapest, HUNGARY
CycloLab is a worldwide recognized and all-around cyclodextrin research and development company, having the longest tradition and broadest circle of customers. Since 1972, a staff of internationally acknowledged experts have been working in the ...
based inPearland, TEXAS (USA)
Our mission is the development of absorbable medical devices with the premise that implants should be safe and effective during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream ...
based inBoston, MASSACHUSETTS (USA)
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
based inPrinceton, NEW YORK (USA)
We are a biopharmaceutical company dedicated to building novel solutions that treat urothelial and specialty cancers. Our breakthrough therapy and innovative clinical pipeline aim to maximize the potential benefit of local delivery with our novel ...
UroGen is developing UGN-102 (mitomycin) for intravesical solution as a primary nonsurgical alternative to repetitive TURBT. UGN-102 is an investigational formulation that utilizes our innovative technology, RTGel™ reverse-thermal hydrogel, ...
